Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer.
Groussin L, Theodon H, Bessiene L, Bricaire L, Bonnet-Serrano F, Cochand-Priollet B, Leroy K, Garinet S, Pasmant E, Zerbit J, Seban R, Goldwasser F, Clerc J, Cottereau AS, Huillard O.
Groussin L, et al. Among authors: clerc j.
Thyroid. 2022 May;32(5):594-598. doi: 10.1089/thy.2021.0524. Epub 2022 Mar 17.
Thyroid. 2022.
PMID: 35171708